Multiple Gi protein subtypes regulate a single effector mechanism

MA Gerhardt and RR Neubig

Department of Pharmacology, University of Michigan Medical School, Ann Arbor 48109-0626.

alpha 2-Adrenergic receptor (alpha 2-AR) responses are mediated by the pertussis toxin-sensitive guanine nucleotide-binding protein (G protein) Gi. Because all three known Gi subtypes are inactivated by pertussis toxin, it has been difficult to determine which of the subtypes are involved in alpha 2-AR responses. In order to investigate alpha 2-AR/Gi coupling, we performed binding and adenylyl cyclase experiments in membranes from CHO-K1 cells transfected with the human alpha 2A-AR. Antisera directed against the carboxyl-terminal region of the Gi1/Gi2 or the Gi3 proteins were used to determine which subtypes were important for high affinity agonist binding and inhibition of adenylyl cyclase. The CHO-K1 cell membranes exhibited immunoreactivity at an apparent molecular mass of 40-41 kDa for both Gi1/Gi2 and Gi3 antisera. Western blot analysis, using purified bovine brain G proteins for comparison, demonstrated that the transfected CHO-K1 cells possess Gi2 and Gi3. High affinity guanosine 5'-(beta,gamma-imido) triphosphate- sensitive binding of the alpha 2-AR agonists [3H]bromoxidine and p- [125I]iodoclonidine ([125I]PIC) was reduced by 30-50% by either the Gi1/Gi2 or Gi3 antiserum. Bromoxidine (1 microM) and PIC (1 microM) inhibited membrane adenylyl cyclase by 34 and 27%, respectively. Gi3 antiserum reduced the inhibition by 26% and 67% for bromoxidine and PIC, respectively. The Gi1/Gi2 antiserum reduced the inhibition by 56% and 63% for bromoxidine and PIC, respectively. Furthermore, when both antisera were used together, there was a complete reversal of alpha 2- AR-mediated inhibition. These observations provide evidence of alpha 2A- AR coupling to at least two subtypes of Gi proteins and the first evidence of functional involvement of Gi3 in the inhibition of adenylyl cyclase.

Volume 40, Issue 5, pp. 707-711, 11/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. J. Clark, C. A. Furman, T. D. Gilson, and J. R. Traynor Comparison of the Relative Efficacy and Potency of {micro}-Opioid Agonists to Activate G{alpha}i/o Proteins Containing a Pertussis Toxin-Insensitive Mutation J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 858 - 864. [Abstract] [Full Text] [PDF]

				H. Zhong, S. M. Wade, P. J. Woolf, J. J. Linderman, J. R. Traynor, and R. R. Neubig A Spatial Focusing Model for G Protein Signals. REGULATOR OF G PROTEIN SIGNALING (RGS) PROTEIN-MEDIATED KINETIC SCAFFOLDING J. Biol. Chem., February 21, 2003; 278(9): 7278 - 7284. [Abstract] [Full Text] [PDF]

				A. Newman-Tancredi, D. Cussac, L. Marini, and M. J. Millan Antibody Capture Assay Reveals Bell-Shaped Concentration-Response Isotherms for h5-HT1A Receptor-Mediated Galpha i3 Activation: Conformational Selection by High-Efficacy Agonists, and Relationship to Trafficking of Receptor Signaling Mol. Pharmacol., September 1, 2002; 62(3): 590 - 601. [Abstract] [Full Text] [PDF]

				C. B. Brink, S. M. Wade, and R. R. Neubig Agonist-Directed Trafficking of Porcine alpha 2A-Adrenergic Receptor Signaling in Chinese Hamster Ovary Cells: l-Isoproterenol Selectively Activates Gs J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 539 - 547. [Abstract] [Full Text]

				S. M. Wade, W. K. Lim, K.-L. Lan, D. A. Chung, M. Nanamori, and R. R. Neubig Gi Activator Region of alpha 2A-Adrenergic Receptors: Distinct Basic Residues Mediate Gi versus Gs Activation Mol. Pharmacol., November 1, 1999; 56(5): 1005 - 1013. [Abstract] [Full Text]

				B. L. Wiens, C. S. Nelson, and K. A. Neve Contribution of Serine Residues to Constitutive and Agonist-Induced Signaling via the D2S Dopamine Receptor: Evidence for Multiple, Agonist-Specific Active Conformations Mol. Pharmacol., August 1, 1998; 54(2): 435 - 444. [Abstract] [Full Text]

				Y.-Z. Gu and A. Schonbrunn Coupling Specificity between Somatostatin Receptor sst2A and G Proteins: Isolation of the Receptor-G Protein Complex with a Receptor Antibody Mol. Endocrinol., May 1, 1997; 11(5): 527 - 537. [Abstract] [Full Text]

				M. N. Garnovskaya, T. W. Gettys, T. van Biesen, V. Prpic, J. K. Chuprun, and J. R. Raymond 5-HT1A Receptor Activates Na+/H+ Exchange in CHO-K1 Cells through Gialpha 2 and Gialpha 3 J. Biol. Chem., March 21, 1997; 272(12): 7770 - 7776. [Abstract] [Full Text] [PDF]

				J. K. Chuprun, J. R. Raymond, and P. J. Blackshear The Heterotrimeric G Protein Galpha i2 Mediates Lysophosphatidic Acid-stimulated Induction of the c-fos Gene in Mouse Fibroblasts J. Biol. Chem., January 10, 1997; 272(2): 773 - 781. [Abstract] [Full Text] [PDF]

				T. Voisin, A.-M. Lorinet, J.-J. Maoret, A. Couvineau, and M. Laburthe Galpha(i) RNA Antisense Expression Demonstrates the Exclusive Coupling of Peptide YY Receptors to G[IMAGE] Proteins in Renal Proximal Tubule Cells J. Biol. Chem., January 5, 1996; 271(1): 574 - 580. [Abstract] [Full Text] [PDF]